{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:51:17Z","timestamp":1777081877606,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08693-7","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T22:45:11Z","timestamp":1734993911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A multi-center, open-label, randomized clinical trial evaluating the preventive effect of perampanel on craniotomy-induced epileptogenesis in seizure-naive patients with supratentorial brain tumors: study protocol for a GRAMPAS trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Junya","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiharu","family":"Ohka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimoto","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nagatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masasuke","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yachiyo","family":"Kuwatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"issue":"4","key":"8693_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s10147-010-0178-y","volume":"16","author":"H Nakamura","year":"2011","unstructured":"Nakamura H, Makino K, Yano S, Kuratsu J. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto prefecture in southern Japan\u201320-year study. Int J Clin Oncol. 2011;16(4):314\u201321.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"8693_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/WCO.0b013e32833e996c","volume":"23","author":"AO Rossetti","year":"2010","unstructured":"Rossetti AO, Stupp R. Epilepsy in brain tumor patients. Curr Opin Neurol. 2010;23(6):603\u20139.","journal-title":"Curr Opin Neurol"},{"key":"8693_CR3","doi-asserted-by":"crossref","unstructured":"Rud\u00e0 R, Bello L, Duffau H, Soffietti R (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol;14 Suppl 4(Suppl 4):iv55\u201364.","DOI":"10.1093\/neuonc\/nos199"},{"issue":"4","key":"8693_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/014107689108400412","volume":"84","author":"MD Shaw","year":"1991","unstructured":"Shaw MD, Foy PM. Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: discussion paper. J R Soc Med. 1991;84(4):221\u20133.","journal-title":"J R Soc Med"},{"issue":"4","key":"8693_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3171\/2012.12.JNS111970","volume":"118","author":"AS Wu","year":"2013","unstructured":"Wu AS, Trinh VT, Suki D, et al. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg. 2013;118(4):873\u201383.","journal-title":"J Neurosurg"},{"issue":"4","key":"8693_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3171\/2015.10.JNS151956","volume":"125","author":"MC Dewan","year":"2016","unstructured":"Dewan MC, White-Dzuro GA, Brinson PR, et al. Perioperative seizure in patients with glioma is associated with longer hospitalization, higher readmission, and decreased overall survival. J Neurosurg. 2016;125(4):1033\u201341.","journal-title":"J Neurosurg"},{"issue":"2","key":"8693_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0028-3886.111118","volume":"61","author":"D Garbossa","year":"2013","unstructured":"Garbossa D, Panciani PP, Angeleri R, et al. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas. Neurol India. 2013;61(2):131\u20137.","journal-title":"Neurol India"},{"issue":"4","key":"8693_CR8","first-page":"192","volume":"2","author":"S Lapointe","year":"2015","unstructured":"Lapointe S, Florescu M, Nguyen DK, et al. Prophylactic anticonvulsants for gliomas: a seven-year retrospective analysis. Neurooncol Pract. 2015;2(4):192\u20138.","journal-title":"Neurooncol Pract"},{"issue":"3","key":"8693_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-009-9977-2","volume":"96","author":"S Lwu","year":"2010","unstructured":"Lwu S, Hamilton MG, Forsyth PA, et al. Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neurooncol. 2010;96(3):403\u20138.","journal-title":"J Neurooncol"},{"issue":"11","key":"8693_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/epi.13562","volume":"57","author":"A Neal","year":"2016","unstructured":"Neal A, Morokoff A, O\u2019Brien TJ, Kwan P. Postoperative seizure control in patients with tumor-associated epilepsy. Epilepsia. 2016;57(11):1779\u201388.","journal-title":"Epilepsia"},{"issue":"4","key":"8693_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.10712","volume":"54","author":"M Klein","year":"2003","unstructured":"Klein M, Engelberts NH, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54(4):514\u201320.","journal-title":"Ann Neurol"},{"issue":"15","key":"8693_CR12","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1212\/01.wnl.0000259411.78423.50","volume":"68","author":"A Jacoby","year":"2007","unstructured":"Jacoby A, Gamble C, Doughty J, et al. Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology. 2007;68(15):1188\u201396.","journal-title":"Neurology"},{"issue":"11","key":"8693_CR13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/neuonc\/noab152","volume":"23","author":"T Walbert","year":"2021","unstructured":"Walbert T, Harrison RA, Schiff D, et al. SNO and EANO practice guideline update: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol. 2021;23(11):1835\u201344.","journal-title":"Neuro Oncol"},{"issue":"6","key":"8693_CR14","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3171\/2016.4.JNS16245","volume":"126","author":"MC Dewan","year":"2017","unstructured":"Dewan MC, Thompson RC, Kalkanis SN, et al. Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS\/CNS Section on Tumors survey. J Neurosurg. 2017;126(6):1772\u20138.","journal-title":"J Neurosurg"},{"issue":"2","key":"8693_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-004-6912-4","volume":"74","author":"V Siomin","year":"2005","unstructured":"Siomin V, Angelov L, Li L, Vogelbaum MA. Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol. 2005;74(2):211\u20135.","journal-title":"J Neurooncol"},{"issue":"7","key":"8693_CR16","first-page":"623","volume":"28","author":"Y Inoue","year":"2012","unstructured":"Inoue Y, Otsuki T, Nakamura H, et al. Efficacy, safety, and pharmacokinetics of fosphenytoin injection in Japanese patients. Rinshouiyaku. 2012;28(7):623\u201333.","journal-title":"Rinshouiyaku"},{"issue":"6","key":"8693_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3171\/2017.2.JNS162315","volume":"128","author":"S Oushy","year":"2018","unstructured":"Oushy S, Sillau SH, Ney DE, et al. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2018;128(6):1713\u20138.","journal-title":"J Neurosurg"},{"issue":"10","key":"8693_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2014-308584","volume":"86","author":"T Iuchi","year":"2015","unstructured":"Iuchi T, Kuwabara K, Matsumoto M, et al. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study. J Neurol Neurosurg Psychiatry. 2015;86(10):1158\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"8693_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/epi.14456","volume":"60","author":"H Potschka","year":"2019","unstructured":"Potschka H, Trinka E. Perampanel: does it have broad-spectrum potential? Epilepsia. 2019;60(Suppl 1):22\u201336.","journal-title":"Epilepsia"},{"issue":"23","key":"8693_CR20","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1021\/jm301268u","volume":"55","author":"S Hibi","year":"2012","unstructured":"Hibi S, Ueno K, Nagato S, et al. Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. J Med Chem. 2012;55(23):10584\u2013600.","journal-title":"J Med Chem"},{"issue":"1","key":"8693_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/epi.12865","volume":"56","author":"PN Patsalos","year":"2015","unstructured":"Patsalos PN. The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist. Epilepsia. 2015;56(1):12\u201327.","journal-title":"Epilepsia"},{"key":"8693_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.25259\/SNI_495_2023","volume":"14","author":"K Kusakabe","year":"2023","unstructured":"Kusakabe K, Inoue A, Watanabe H, et al. Perioperative perampanel administration for early seizure prophylaxis in brain tumor patients. Surg Neurol Int. 2023;14:287.","journal-title":"Surg Neurol Int"},{"issue":"1","key":"8693_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2176\/nmc.oa.2018-0245","volume":"60","author":"M Chonan","year":"2020","unstructured":"Chonan M, Saito R, Kanamori M, et al. Experience of low dose perampanel to add-on in glioma patients with levetiracetam-uncontrollable epilepsy. Neurol Med Chir (Tokyo). 2020;60(1):37\u201344.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"11","key":"8693_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","volume":"85","author":"JA French","year":"2015","unstructured":"French JA, Krauss GL, Wechsler RT, et al. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial. Neurology. 2015;85(11):950\u20137.","journal-title":"Neurology"},{"key":"8693_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346: e7586.","journal-title":"BMJ"},{"key":"8693_CR26","unstructured":"(2020) Pharmaceuticals and Medical Devices Agency (PMDA). Fycompa prescribing information [Japanese]."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08693-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T11:02:31Z","timestamp":1735038151000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08693-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8693"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08693-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4667681\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was granted by the Ethics Committee of Nagoya University Hospital on December 7, 2023 (approval number: 2023-0348). This study has been registered and jRCT (approval number: jRCTs041230117). jRCT is an approved member of the Primary Registry Network of WHO ICTRP. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"849"}}